Evidence map›Paper›PMID 41450627›Full record

ArticleJACS Au2025

A Facile and Reproducible Method for the Purification of Peptide- and Protein-Functionalized DNA Nanostructures.

Izar Schärf, Anna Paton, Betül Karakoc, Bianca Greul, Anna Scheeder, Paraskevi Nani, Pol Saludes Peris, Maria Zacharopoulou, Viktorija Glembockyte, Ioanna Mela

Abstract read
In one paragraph

Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Izar SchärfDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K.ORCID https://orcid.org/0009-0007-6024-9464
Anna PatonDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K.
Betül KarakocMax Planck Institute for Medical Research, Jahnstr. 29, 69120 Heidelberg, Germany.
Bianca GreulDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K.
Anna ScheederDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K.ORCID https://orcid.org/0009-0004-0042-6578
Paraskevi NaniDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K.
Pol Saludes PerisDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K.
Maria ZacharopoulouDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K.ORCID https://orcid.org/0000-0002-3660-2797
Viktorija GlembockyteMax Planck Institute for Medical Research, Jahnstr. 29, 69120 Heidelberg, Germany.ORCID https://orcid.org/0000-0003-2531-6506
Ioanna MelaDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, U.K.ORCID https://orcid.org/0000-0002-2914-9971

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA nanotechnology has emerged as a promising field for biomedical applications, in both the therapeutic and diagnostic domains. The ability of DNA nanostructures to carry cargos in precise numbers and orientations makes them competitive candidates for drug delivery, biosensors, or imaging agents. Two of the main challenges for translating DNA nanostructures from the laboratory to the clinic are achieving cost-effective large-scale production and establishing comprehensive safety profiles. Having the ability to reliably and efficiently purify functionalized DNA nanostructures is key to both challenges and an open question in the field of DNA nanotechnology. Here we present a scalable method for the fast and efficient purification of a high concentration of peptide- or protein-functionalized DNA nanostructures. We use a gravity-driven size exclusion chromatography approach that has the potential to purify DNA nanostructures within 10 min in yields of up to 93% with purities of over 99.9% and is appropriate for both protein and peptide conjugates.

Indexed as

DNA NanotechnologyFunctionalizationPeptideProteinPurificationSize Exclusion Chromatography (SEC)

Identifiers

PMID41450627
PMCPMC12728597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.